Chlorine in PDB 6fz5: Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound
Enzymatic activity of Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound
All present enzymatic activity of Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound:
2.3.1.97;
Protein crystallography data
The structure of Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound, PDB code: 6fz5
was solved by
F.C.Kersten,
R.Brenk,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
76.94 /
1.89
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
92.390,
58.160,
154.001,
90.00,
92.36,
90.00
|
R / Rfree (%)
|
18.9 /
22.3
|
Other elements in 6fz5:
The structure of Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound
(pdb code 6fz5). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound, PDB code: 6fz5:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 6fz5
Go back to
Chlorine Binding Sites List in 6fz5
Chlorine binding site 1 out
of 4 in the Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1000
b:93.2
occ:1.00
|
CL1
|
A:BXN1000
|
0.0
|
93.2
|
1.0
|
C15
|
A:BXN1000
|
1.8
|
80.1
|
1.0
|
C17
|
A:BXN1000
|
2.8
|
76.1
|
1.0
|
C14
|
A:BXN1000
|
2.8
|
77.5
|
1.0
|
O12
|
A:BXN1000
|
3.1
|
83.8
|
1.0
|
S11
|
A:BXN1000
|
3.3
|
79.7
|
1.0
|
O
|
A:HOH1238
|
3.4
|
43.6
|
1.0
|
N09
|
A:BXN1000
|
3.5
|
73.2
|
1.0
|
C10
|
A:BXN1000
|
3.5
|
71.1
|
1.0
|
N
|
A:GLY472
|
3.9
|
46.6
|
1.0
|
C07
|
A:BXN1000
|
4.0
|
64.0
|
1.0
|
CA
|
A:GLY472
|
4.1
|
49.2
|
1.0
|
C18
|
A:BXN1000
|
4.1
|
71.9
|
1.0
|
C32
|
A:BXN1000
|
4.1
|
74.4
|
1.0
|
O
|
A:HOH1252
|
4.2
|
49.6
|
1.0
|
C08
|
A:BXN1000
|
4.5
|
67.4
|
1.0
|
C31
|
A:BXN1000
|
4.6
|
71.0
|
1.0
|
C06
|
A:BXN1000
|
4.8
|
63.7
|
1.0
|
C
|
A:ASP471
|
4.8
|
48.5
|
1.0
|
CB
|
A:ASP471
|
4.8
|
48.8
|
1.0
|
N
|
A:ASP471
|
4.9
|
45.2
|
1.0
|
O13
|
A:BXN1000
|
4.9
|
73.0
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 6fz5
Go back to
Chlorine Binding Sites List in 6fz5
Chlorine binding site 2 out
of 4 in the Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1000
b:79.9
occ:1.00
|
CL2
|
A:BXN1000
|
0.0
|
79.9
|
1.0
|
C32
|
A:BXN1000
|
1.8
|
74.4
|
1.0
|
O13
|
A:BXN1000
|
2.6
|
73.0
|
1.0
|
C31
|
A:BXN1000
|
2.7
|
71.0
|
1.0
|
C14
|
A:BXN1000
|
2.8
|
77.5
|
1.0
|
OH
|
A:TYR420
|
2.9
|
32.8
|
1.0
|
S11
|
A:BXN1000
|
3.3
|
79.7
|
1.0
|
CE2
|
A:TYR420
|
3.6
|
28.5
|
1.0
|
CZ
|
A:TYR420
|
3.7
|
29.8
|
1.0
|
CZ
|
A:PHE190
|
4.0
|
45.0
|
1.0
|
CE1
|
A:PHE190
|
4.0
|
43.7
|
1.0
|
C18
|
A:BXN1000
|
4.1
|
71.9
|
1.0
|
C15
|
A:BXN1000
|
4.1
|
80.1
|
1.0
|
C08
|
A:BXN1000
|
4.2
|
67.4
|
1.0
|
N09
|
A:BXN1000
|
4.3
|
73.2
|
1.0
|
ND2
|
A:ASN451
|
4.4
|
31.9
|
1.0
|
C06
|
A:BXN1000
|
4.4
|
63.7
|
1.0
|
CE1
|
A:TYR296
|
4.4
|
45.0
|
1.0
|
CD1
|
A:TYR296
|
4.5
|
43.1
|
1.0
|
O12
|
A:BXN1000
|
4.6
|
83.8
|
1.0
|
CZ
|
A:TYR296
|
4.6
|
45.7
|
1.0
|
C17
|
A:BXN1000
|
4.6
|
76.1
|
1.0
|
C02
|
A:BXN1000
|
4.7
|
64.6
|
1.0
|
C07
|
A:BXN1000
|
4.7
|
64.0
|
1.0
|
CG
|
A:TYR296
|
4.8
|
39.2
|
1.0
|
N04
|
A:BXN1000
|
4.8
|
59.8
|
1.0
|
CE2
|
A:TYR296
|
4.9
|
44.1
|
1.0
|
CG
|
A:ASN451
|
4.9
|
30.3
|
1.0
|
CE1
|
A:HIS298
|
4.9
|
36.2
|
1.0
|
CD2
|
A:TYR296
|
4.9
|
43.2
|
1.0
|
CD2
|
A:TYR420
|
4.9
|
26.7
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 6fz5
Go back to
Chlorine Binding Sites List in 6fz5
Chlorine binding site 3 out
of 4 in the Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl1000
b:76.0
occ:1.00
|
CL1
|
B:BXN1000
|
0.0
|
76.0
|
1.0
|
C15
|
B:BXN1000
|
1.8
|
62.4
|
1.0
|
C17
|
B:BXN1000
|
2.7
|
59.6
|
1.0
|
C14
|
B:BXN1000
|
2.8
|
59.5
|
1.0
|
O12
|
B:BXN1000
|
3.0
|
61.5
|
1.0
|
S11
|
B:BXN1000
|
3.3
|
63.5
|
1.0
|
N09
|
B:BXN1000
|
3.6
|
57.4
|
1.0
|
C10
|
B:BXN1000
|
3.6
|
58.2
|
1.0
|
N
|
B:GLY472
|
3.7
|
44.3
|
1.0
|
CA
|
B:GLY472
|
3.8
|
43.9
|
1.0
|
C18
|
B:BXN1000
|
4.1
|
54.9
|
1.0
|
C32
|
B:BXN1000
|
4.1
|
58.5
|
1.0
|
C07
|
B:BXN1000
|
4.1
|
46.2
|
1.0
|
C31
|
B:BXN1000
|
4.6
|
56.8
|
1.0
|
C08
|
B:BXN1000
|
4.6
|
50.6
|
1.0
|
C
|
B:ASP471
|
4.7
|
46.4
|
1.0
|
C06
|
B:BXN1000
|
4.8
|
47.0
|
1.0
|
N
|
B:ASP471
|
4.9
|
44.9
|
1.0
|
O13
|
B:BXN1000
|
4.9
|
60.2
|
1.0
|
CB
|
B:ASP471
|
4.9
|
50.3
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 6fz5
Go back to
Chlorine Binding Sites List in 6fz5
Chlorine binding site 4 out
of 4 in the Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Human N-Myristoyltransferase (NMT1) with Myristoyl-Coa and Inhibitor Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl1000
b:62.5
occ:1.00
|
CL2
|
B:BXN1000
|
0.0
|
62.5
|
1.0
|
C32
|
B:BXN1000
|
1.8
|
58.5
|
1.0
|
O13
|
B:BXN1000
|
2.7
|
60.2
|
1.0
|
C14
|
B:BXN1000
|
2.7
|
59.5
|
1.0
|
C31
|
B:BXN1000
|
2.8
|
56.8
|
1.0
|
OH
|
B:TYR420
|
2.9
|
33.6
|
1.0
|
S11
|
B:BXN1000
|
3.2
|
63.5
|
1.0
|
CZ
|
B:TYR420
|
3.8
|
31.4
|
1.0
|
CZ
|
B:PHE190
|
3.8
|
35.6
|
1.0
|
CE2
|
B:TYR420
|
3.8
|
30.8
|
1.0
|
CE1
|
B:PHE190
|
3.8
|
35.5
|
1.0
|
C08
|
B:BXN1000
|
4.0
|
50.6
|
1.0
|
C15
|
B:BXN1000
|
4.0
|
62.4
|
1.0
|
C18
|
B:BXN1000
|
4.1
|
54.9
|
1.0
|
C06
|
B:BXN1000
|
4.2
|
47.0
|
1.0
|
N09
|
B:BXN1000
|
4.2
|
57.4
|
1.0
|
CE1
|
B:TYR296
|
4.4
|
37.7
|
1.0
|
C02
|
B:BXN1000
|
4.4
|
49.7
|
1.0
|
CZ
|
B:TYR296
|
4.5
|
38.7
|
1.0
|
N04
|
B:BXN1000
|
4.5
|
45.5
|
1.0
|
C17
|
B:BXN1000
|
4.6
|
59.6
|
1.0
|
CD1
|
B:TYR296
|
4.6
|
37.8
|
1.0
|
ND2
|
B:ASN451
|
4.6
|
33.6
|
1.0
|
C07
|
B:BXN1000
|
4.6
|
46.2
|
1.0
|
O12
|
B:BXN1000
|
4.6
|
61.5
|
1.0
|
N03
|
B:BXN1000
|
4.7
|
46.1
|
1.0
|
CE2
|
B:TYR296
|
4.8
|
37.7
|
1.0
|
CG
|
B:TYR296
|
4.9
|
38.2
|
1.0
|
OH
|
B:TYR296
|
4.9
|
39.6
|
1.0
|
CD2
|
B:TYR296
|
5.0
|
39.7
|
1.0
|
|
Reference:
C.Kersten,
E.Fleischer,
J.Kehrein,
C.Borek,
E.Jaenicke,
C.Sotriffer,
R.Brenk.
How to Design Selective Ligands For Highly Conserved Binding Sites: A Case Study Usingn-Myristoyltransferases As A Model System. J.Med.Chem. 2019.
ISSN: ISSN 0022-2623
PubMed: 31423787
DOI: 10.1021/ACS.JMEDCHEM.9B00586
Page generated: Sat Jul 27 23:36:40 2024
|